Meeting
Abstract Number: 77
Hospital Medicine 2016, March 6-9, San Diego, Calif.
Background: Disparities in screening mammography use persist among low-income women, even those who are insured, despite the proven mortality benefit. We evaluated the prevalence of breast cancer screening non-adherence among hospitalized women and their receptivity to inpatient screening mammography as a novel approach to increase breast cancer screening rate. Methods: A cross sectional study was […]
Abstract Number: 83
Hospital Medicine 2017, May 1-4, 2017; Las Vegas, Nev.
Background: Approximately 15% of women in the United States aged 35-79 year are at high risk for developing breast cancer, however less than 0.2% of these women reported taking chemoprevention to reduce their risk. Objective of the study was to characterize the current utilization of chemoprevention agents among hospitalized women who are at higher risk […]
Abstract Number: D9
SHM Converge 2022
Background: Despite the proven mortality benefit of screening colonoscopy, approximately 27% of hospitalized women are non-adherent with colorectal cancer screening guidelines. Colonoscopy is the most frequently used test for colorectal cancer screening in US. Although Medicare and most insurance plans would cover screening colonoscopy, colorectal cancer screening has not been part of usual hospital care. […]
Abstract Number: 132
Hospital Medicine 2018; April 8-11; Orlando, Fla.
Background: Breast cancer is the most common malignancy and the second leading cause of cancer death among women in the United States. Disparities in screening mammography use persists among low income women, even those who are insured, despite the proven mortality benefit. More than a third of hospitalized women are both overdue for breast cancer […]